March 17, 2009
CMS Agrees to Suspend Implementation of Phase VIII MUE’s Claims Payment
Courtesy of the American Pathology Foundation. Good news for pathologists concerning reimbursement codes, particularly for the one most widely used for biopsies.
APF NEWS ALERT! |
CMS Agrees to Suspend Implementation of Phase VIII MUE's Claims Payment For Immediate Release temporarily  suspend implementation of Phase VIII MUE's,including those CPT codes of most interest and concern to pathologists–such as the 88305. This decision followed a frank and fruitful meeting between representatives of the American Clinical Laboratory Association (ACLA) and the College of American Pathologists (Stephen Black-Shaffer, MD, Vice-Chair of the CAP's Economic Affairs Committee). CMS agreed to schedule a follow-up discussion to better understand and address the concerns of pathologists and the clinical laboratory industry about the lack of transparency, among other things, with the current MUE review process. Contact the APF National Office with any questions you have regarding this message: info@apfconnect.org or 877-993-9935 |
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing